NCT07349069 2026-03-19
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3 Recruiting
Shandong Suncadia Medicine Co., Ltd.
Eli Lilly and Company
Merck Sharp & Dohme LLC
Sanofi